癌症中的β-腺素受体:老玩家和新的视角
Rosario Amato1, Martina Lucchesi1, Silvia Marracci1
1Department of Biology, University of Pisa, Pisa, Italy.
Handbook of experimental pharmacology
|November 20, 2023
概括
负面压力通过通过β-上腺体受体 (β-ARs) 激活甲醇胺加速癌症. β抑制剂在减少瘤生长和通过向这些受体来改善结果方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 压力生理学 压力生理学
背景情况:
- 痛苦与癌症发病率和进展的增加有关.
- 由β-腺受体 (β-ARs) 介导的catecholaminergic过度驱动促进了瘤的生长.
- 临床研究表明,负面压力会影响癌症的进展.
研究的目的:
- 审查β-腺受体 (β-AR) 异型在癌症中的作用.
- 突出最近关于β-ARs作为瘤学治疗点的发现.
- 探索焦虑对致癌和瘤进展的影响.
主要方法:
- 关于压力和癌症的临床前模型和临床研究的审查.
- 分析β-AR亚型 (β1-AR,β2-AR,β3-AR) 在瘤发育中的参与.
- 检查β-阻断剂在癌症治疗中的治疗潜力.
主要成果:
- 压力诱导的甲基胺过度驱动通过β-AR激活促进癌细胞的生长和进展.
- β2-AR似乎是主要的调解者,但β1-AR和β3-AR也可能在特定瘤中发挥作用.
- β-阻断剂在抵消由甲醇胺驱动的瘤原生活性方面表现出积极的效果.
结论:
- β-腺受体 (β-ARs) 是癌症进展的关键调节者.
- 向β-ARs代表了对各种癌症的有希望的治疗策略.
- 了解β-AR异构体的特定作用可以导致更有效的癌症治疗.
相关概念视频
Adrenergic Receptors (Adrenoceptors): Classification
2.6K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.6K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
861
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
861
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


